CLOV — Clover Health Investments, Corp. stock price, charts and financials

NASDAQ·Healthcare·Medical - Healthcare Plans·USA

Latest market price

4.46

-0.08-1.76%

Overview Short InterestFilings

CLOVQT70Clover Health Investments, Corp.·NASDAQ

Overview Short InterestFilings

4.46-1.76%

News

Down 1.8% — Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens (marketbeat.com).

Medium confidence

Loading chart...

Signal & projected range

Insider selling clusterHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

PGNY+0.44%$27.13 ALHC-4.02%$8.35 OSCR+0.47%$32.13 MOH-2.10%$200.79 CNC-2.97%$65.11 HUM+0.44%$386.22 CI-0.26%$275.28 ELV-0.80%$410.95

Snapshot

Index	-	P/E	-	EPS (ttm)	-0.04	Insider Own	-	Shs Outstand	518.26M	Perf Week	-7.47%

Market Cap	2.31B	Forward P/E	44.43	EPS next Y	0.10	Insider Trans	-0.52%	Shs Float	408.51M	Perf Month	5.69%

Enterprise Value	2.11B	PEG	5.49	EPS next Q	0.00	Inst Own	-	Short Float	5.80%	Perf Quarter	-10.80%

Income	-18.26M	P/S	0.93	EPS this Y	240.10%	Inst Trans	-	Short Ratio	3.89	Perf Half Y	135.98%

Sales	2.48B	P/B	6.21	EPS next Y	79.15%	ROA	-2.55%	Short Interest	23.68M	Perf YTD	89.79%

Book/sh	-	P/C	30.35	EPS next 5Y	43.86%	ROE	-5.38%	52W High	5.59 -20.21%	Perf Year	45.28%

Cash/sh	-	P/FCF	31.15	EPS past 3/5Y	-	ROIC	-4.63%	52W Low	1.58 182.28%	Perf 3Y	265.57%

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.60% 23.38%	Gross Margin	18.57%	Volatility	6.24% 4.38%	Perf 5Y	-48.08%

Dividend TTM	-	EV/Sales	0.85	EPS Y/Y TTM	54.44%	Oper. Margin	-0.74%	ATR (14)	0.24	Perf 10Y	-

Dividend Ex-Date	Aug 23, 2021	Quick Ratio	1.50	Sales Y/Y TTM	80.67%	Profit Margin	-0.74%	RSI (14)	50.02	Recom	3.22

Dividend Gr. 3/5Y	-	Current Ratio	1.50	EPS Q/Q	-	SMA20	1.54%	Beta	2.45	Target Price	5.50

Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	55.44%	SMA50	0.85%	Rel Volume	1.23	Prev Close	4.54

Employees	724	LT Debt/Eq	0.01	Earnings	Nov 03	SMA200	37.65%	Avg Volume	5.00M	Price	4.46

IPO Date	Jun 12, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.40% 2.05%	Net Debt/EBITDA	12.08	Volume	6,160,985	Change	-1.76%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Sep-10-26	Initiated	Deutsche Bank	Buy	$6.00
Aug-06-26	Reiterated	UBS	Neutral	$4.75 → $5.00
Jul-21-26	Reiterated	Canaccord Genuity	Buy	$4.20 → $5.50
Jun-11-26	Reiterated	UBS	Neutral	$4.75
Jun-04-26	Reiterated	Canaccord Genuity	Buy	$2.50 → $4.20
Oct-21-25	Reiterated	Leerink Partners		$3.00
Dec-17-24	Initiated	Craig-Hallum	Buy	$6.00
Aug-06-24	Reiterated	Canaccord Genuity	Buy	$2.50
Nov-16-22	Reiterated	Citigroup	Neutral	$1.80
Feb-02-22	Upgrade	Cowen & Co.	Underperform → Market Perform

Latest News· Times ET

Sep-18-26

Sep-18-2605:02AM

Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightensmarketbeat.com

Sep-17-26

Sep-17-2612:13AM

Tidal Investments LLC Takes $2.16 Million Position in Clover Health Investments, Corp. $CLOVdefenseworld.net

Sep-15-26

Sep-15-2609:21PM

Clover Health Investments (NASDAQ:CLOV) Stock Price Down 6.5% Following Insider Sellingdefenseworld.net

06:55PM

Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To KnowYahoo

Sep-10-26

Sep-10-2606:02AM

Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On ThursdayBenzinga

Sep-03-26

Sep-03-2608:15AM

3 Penny Stocks Trading Up To 94% Below Fair ValueYahoo

Aug-31-26

Aug-31-2612:05PM

Clover Health to Participate in Upcoming Investor Conferencesglobenewswire.com

Aug-26-26

Aug-26-2604:24AM

Clover Health Is A 'Buy' Because Of Its AIseekingalpha.com

Aug-18-26

Aug-18-2610:18PM

Clover Health's High Valuation Ignores Low-Margin Structural RealitiesSeekingAlpha

Aug-15-26

Aug-15-2612:16AM

Clover Health Investments: Real Turnaround, But Already Priced Inseekingalpha.com

Aug-14-26

Aug-14-2605:11AM

Clover Health Is Proving Its Profit Modelseekingalpha.com

Aug-13-26

Aug-13-2603:15PM

Clover Health Investments, Corp. (CLOV) Presents at Canaccord Genuity's 46th Annual Growth Conference - SlideshowSeekingAlpha

Aug-11-26

Aug-11-2607:06AM

Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growthmarketbeat.com

Aug-06-26

Aug-06-2611:04AM

UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5Benzinga

Aug-05-26

Aug-05-2604:50PM

Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcriptseekingalpha.com

Company

Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	2,477	1,924	1,371	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	2,016	1,568	1,006	—	—	—	—	—	—
Gross Profit	460	356	365	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	213	176	409	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	266	265	2	—	—	—	—	—	—
Operating Income	-18	-86	-46	—	—	—	—	—	—
Interest Expense	0	0	0	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	0	0	-1	—	—	—	—	—	—
Net Income Before Taxes	-18	-86	-46	—	—	—	—	—	—
Income Taxes	0	0	0	—	—	—	—	—	—
Consolidated Net Income	-18	-86	-43	—	—	—	—	—	—
Net Income From Continuing Operations	-18	-86	-46	—	—	—	—	—	—
Net Income	-18	-86	-43	—	—	—	—	—	—
EPS (Recurring)	-0.04	-0.17	-0.09	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-0.04	-0.17	-0.09	—	—	—	—	—	—
EPS (Diluted)	-0.04	-0.17	-0.09	—	—	—	—	—	—
EBITDA	-16	-84	-45	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	0.94	0.63	1.13	—	—	—	—	—	—
Gross Margin	18.57	18.50	26.62	—	—	—	—	—	—
Operating Margin	-0.73	-4.47	-3.36	—	—	—	—	—	—
Net Margin	-0.73	-4.47	-3.14	—	—	—	—	—	—
Shares Outstanding	524	517	490	—	—	—	—	—	—
Market Capitalization	2,337	1,215	1,544	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Reynoso Jamie L.	CEO, Medicare Advantage	Sep 17 '26	Sale	4.56	1,921	8,760	2,803,446	Sep 18
OLDAKOWSKI JOSEPH FRANK	VP OF FINANCE AND CONTROLLER	Sep 16 '26	Sale	4.64	3,170	14,709	275,897	Sep 17
Wai Conrad	CEO, Counterpart Health	Sep 15 '26	Sale	4.72	300,000	1,416,000	1,170,056	Sep 16
Reynoso Jamie L.	CEO, Medicare Advantage	Sep 15 '26	Sale	4.78	9,273	44,325	2,805,367	Sep 15
Soares Karen	Chief Legal Officer	Sep 15 '26	Sale	4.78	6,846	32,724	1,607,371	Sep 15
OLDAKOWSKI JOSEPH FRANK	VP OF FINANCE AND CONTROLLER	Sep 14 '26	Sale	5.16	20,000	103,200	279,067	Sep 14
THORNTON JOSEPH CLAY	Interim CFO	Aug 17 '26	Sale	4.39	17,775	78,032	1,249,526	Aug 17
Toy Andrew	Chief Executive Officer	Aug 10 '26	Sale	4.65	87,798	408,261	9,459,316	Aug 10
Soares Karen	Chief Legal Officer	Jul 20 '26	Sale	4.51	51,700	233,167	1,505,522	Jul 20
Reynoso Jamie L.	CEO, Medicare Advantage	Jul 17 '26	Sale	4.53	4,839	21,921	2,814,640	Jul 17
Toy Andrew	Chief Executive Officer	Jul 15 '26	Sale	4.67	62,711	292,860	9,547,114	Jul 16
Wai Conrad	CEO, Counterpart Health	Jul 15 '26	Sale	4.67	24,215	113,084	1,145,699	Jul 16
Reynoso Jamie L.	CEO, Medicare Advantage	Jul 15 '26	Sale	4.67	13,119	61,266	2,819,479	Jul 16
Soares Karen	Chief Legal Officer	Jul 15 '26	Sale	4.67	10,519	49,124	1,557,222	Jul 16
THORNTON JOSEPH CLAY	Interim CFO	Jul 15 '26	Sale	4.67	4,630	21,622	1,212,954	Jul 16

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.